Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 6

Review Article

An Overview of the Randomized Placebo-Controlled Trials of Chinese Herbal Medicine Formula Granules

Table 6

The overview of the effectiveness of CHM formula granules only.

DiseasesNo. of studiesCure rateEffectiveness rate
CHM granulesPlaceboCHM granulesPlacebo

HBV carrier/recrudescence
HBV DNA (HBeAg)
53.1% (7.4%)0.5% (3.8%)20.8%5.3%
Chronic hepatitis C
HCV RNA
316.9%3.0%--
Non-alcoholic fatty liver147.5%25.0%82.5%52.5%
Depression228.4%10.5%78.9%44.2%
Fever262.9%40.0%94.4%87.5%
Migraine14.2%0.0%74.8%74.2%
AIDS1--38.9%16.7%

P<0.05 (result of individual study or meta-analysis).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.